One of the smoking guns in the ongoing Trump administration probe into the COVID-19 cover-up is evidence suggesting that the Chinese suspected the novel virus may have neurological symptoms just weeks after it was officially identified, despite the fact that coronaviruses, historically, primarily affect the respiratory and digestive systems.
Specifically, two scientists listed as authors on the first Chinese patent for a COVID-19 vaccine—that remarkably came about a month after the virus crossed the border into the U.S.—are affiliated with a neuroscience institute in Beijing that works closely with the Chinese military.
The presence of these two researchers on the early 2020 vaccine patent in China is puzzling to federal investigators probing the origins of COVID-19, and its cover-up, because many of the virus’s long-term neurological effects were not a focus of Western scientists until much later.
Patent filed in China one month after COVID hits U.S.
The patent was filed on February 24, 2020, only about one month after the first laboratory-confirmed COVID-19 case appeared in the United States and shortly before the World Health Organization declared the spread of the virus a global health pandemic.
Click this link for the original source of this article.
Author: Ray Hilbrich
This content is courtesy of, and owned and copyrighted by, https://www.offthepress.com and its author. This content is made available by use of the public RSS feed offered by the host site and is used for educational purposes only. If you are the author or represent the host site and would like this content removed now and in the future, please contact USSANews.com using the email address in the Contact page found in the website menu.
